NewGenIvf Group (NASDAQ:NIVF) and Marpai (NASDAQ:MRAI) Head-To-Head Survey

Marpai (NASDAQ:MRAI) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Marpai and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Marpai	-92.76%	N/A	-99.32%
NewGenIvf Group	N/A	N/A	N/A

Valuation & Earnings

This table compares Marpai and NewGenIvf Group”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87 million	0.16	-$28.75 million	($3.19)	-0.16
NewGenIvf Group	$5.14 million	0.47	$130,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than Marpai.

Risk and Volatility

Marpai has a beta of 4.85, indicating that its stock price is 385% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500.

Institutional and Insider Ownership

49.8% of Marpai shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 61.3% of Marpai shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent recommendations for Marpai and NewGenIvf Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0	0	1	0	3.00
NewGenIvf Group	0	0	0	0	N/A

Marpai presently has a consensus price target of $6.00, suggesting a potential upside of 1,053.85%. Given Marpai’s higher probable upside, equities research analysts clearly believe Marpai is more favorable than NewGenIvf Group.

About Marpai

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.